Search results
Results from the WOW.Com Content Network
A 2017 review suggests that cannabis has been shown to improve the mood of depression-diagnosed patients. [13] This is indicative of a longitudinal relationship between cannabis reduction and improvements in anxiety and depression. Anxiety and depression have been found to increase susceptibility to marijuana use. [55]
A growing body of research links marijuana use among some young adults to mental health issues such as schizophrenia, bipolar disorder and depression.
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
Cannabis use disorder is defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders as a condition requiring treatment. [107] Several drugs have been investigated in an attempt to ameliorate the symptoms of stopping cannabis use. Such drugs include bupropion, divalproex, nefazodone, lofexidine, and dronabinol.
Evidence from separate Danish and British studies, among others, suggest a link between heavy marijuana use and psychiatric disorders such as depression, bipolar disorder and schizophrenia ...
Weed affects your ability to make decisions, control emotions, remember important data, plan, organize and solve problems, a new study found, and that impact may last well past your initial high.
Cannabis use disorder (CUD), also known as cannabis addiction or marijuana addiction, is a psychiatric disorder defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders and ICD-10 as the continued use of cannabis despite clinically significant impairment. [2] [3]
Canadian researchers examined the health records of more than 12 million people living in Ontario between 2008 and 2019 who had no record of an anxiety disorder, or of receiving treatment for one.